Ronawk builds programmable infrastructure for mammalian cell manufacturing. Its platform, Bio-OS, integrates materials, workflows, and measurement systems to create controlled environments that enable reproducible and scalable cell production. The company is initially focused on improving mesenchymal stem cell manufacturing for CDMOs in the cell and gene therapy industry, where variability, cost of goods, and slow tech transfer limit the ability to scale advanced therapies. By providing a programmable biological environment, Bio-OS helps manufacturers produce higher-quality cells with greater consistency and portability across production sites. Over time, the platform expands into additional cell systems such as iPSCs, primary cells, and tissue models.
